1. Home
  2. Pharma and Healthcare

Category: Pharma and Healthcare

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

Malvern, PA, Cambridge, UK, and Sandwich, UK, May 17, 2022 – Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC. KKR

NovaQuest strikes $500m hard cap for latest life science, pharma services-focused private equity fund

NovaQuest Capital Management has struck a $500m hard cap close for its latest private equity investment fund. The post NovaQuest strikes $500m hard cap for latest life science, pharma services-focused private equity fund first appeared

QPE backs MBO of Republic M!

London-based Queen's Park Equity has acquired Republic M! (RM!), which provides digital media services for the healthcare sector, in a management buyout.

Permira to sell healthcare technology management Althea to infrastructure investorsF2i, DWS

Global buyout major Permira has agreed to sell healthcare technology management services provider Althea Group to a consortium formed by infrastructure investors F2i and DWS. The post Permira to sell healthcare technology management Althea to

ArchiMed exits Eurolyser to trade for 6x return

Healthcare specialist private equity firm ArchiMed has sold Austrian point-of-care testing specialist Eurolyser to the veterinary diagnostics arm of Mars Incorporated for a 6x return.

Oak Hill Capital adds healthcare veteran David Pryor as senior advisor

Oak Hill Capital Partners has hired healthcare veteran David Pryor as a senior advisor. The post Oak Hill Capital adds healthcare veteran David Pryor as senior advisor first appeared on AltAssets Private Equity News.

Rare disease pharmacy specialist PANTHERx bought by private equity consortium

Nautic Partners, The Vistria Group and General Atlantic have agreed to buy rare pharmacy care specialist PANTHERx Rare from Centene Corporation. The post Rare disease pharmacy specialist PANTHERx bought by private equity consortium first appeared on

Teachers' Venture Growth leads Alan's EUR 183m Series E

Teachers' Venture Growth (TVG), the venture arm of the Ontario Teachers’ Pension Plan Board, has led a EUR 183m Series E investment in French health tech company Alan.

Roundtable Healthcare Partners passes $4bn of capital raised thanks to Fund VI final close

RoundTable Healthcare Partners has hit an $800m final close for its sixth private equity fund, bringing its total raised since inception to $4.25bn. The post Roundtable Healthcare Partners passes $4bn of capital raised thanks to

Astorg beats sponsors to acquire CordenPharma

Private equity firm Astorg has acquired German CDMO CordenPharma from International Chemical Investors Group (ICIG).

Astorg agrees CordenPharma carve-out in deal said to exceed €2.5bn

French private equity group Astorg has agreed a buyout of drug contract development and manufacturing business CordenPharma in a deal reportedly worth more than €2.5bn. The post Astorg agrees CordenPharma carve-out in deal said to exceed

Gilde Healthcare's RAD-X joins busy radiology pipeline

Gilde Healthcare has mandated Lincoln International to sell DACH radiology asset RAD-X, according to four sources familiar with the situation.

Welsh Carson more than 80% of way to $5bn Fund XIV target, could reach $5.5bn hard cap

Healthcare and tech-focused private equity major Welsh, Carson, Anderson & Stowe is more than 80% of the way to its $5bn target for its latest flagship fundraise. The firm has registered just over $4bn of commitments

MassMutual Ventures makes European push with new $300m fund

US and Asia-based investor MassMutual Ventures has expanded to Europe through the launch of a $300m fund targeting early and growth-stage companies in digital health, financial technology, enterprise SaaS and cybersecurity. The post MassMutual Ventures makes

HealthTech investor Flare Capital strikes $350m goal in third flagship fundraise

HealthTech-focused Flare Capital Partners has reached the $350m target for its third flagship fundraise. The post HealthTech investor Flare Capital strikes $350m goal in third flagship fundraise first appeared on AltAssets Private Equity News.

Healthcare-focused Lead Capital Partners brings in ex-Gen Cap America exec Stanley as director

Healthcare-focused buyout house Lead Capital Partners has hired former Gen Cap America senior exec Lamar Stanley as a director. The post Healthcare-focused Lead Capital Partners brings in ex-Gen Cap America exec Stanley as director first

Enhanced Healthcare Partners promotes Einstein to partner

Enhanced Healthcare Partners has promoted Brandon Einstein to partner after seven years with the firm. The post Enhanced Healthcare Partners promotes Einstein to partner first appeared on AltAssets Private Equity News.

Texas County and District Retirement System reveals more PE, VC fund commitments

The Texas County and District Retirement System has agreed more than $100m of new private equity and venture capital commitments. TCDRS said it would commit $95m to Water Street Healthcare Partners V, a $1.4bn private

Inflexion acquires CDMO Upperton

Mid-market private equity firm Inflexion has acquired British CDMO Upperton Pharma Solutions.

Inflexion buys into pharma industry particle engineering specialist Upperton

European buyout house Inflexion Private Equity has made what it calls a "substantial" investment into UK specialist contract development and manufacturing organisation Upperton Pharma Solutions. The post Inflexion buys into pharma industry particle engineering specialist Upperton

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.